Below, we summarize the relevance of the PI3K/Akt/mTOR pathways and the effector molecules in diverse skin cancers and discuss the mechanistic role of several synthetic molecules and dietary phytochemicals in inhibiting these pathways as potential therapeutic approaches. This evidence concerns the gene AKT1 and skin cancer.